This website uses cookies, which are necessary for you to login to the My ICCA section, integrate social media and track visits to our website. ICCA is legally obliged to ask your permission to use cookies and to inform you about how we use them. By continuing to use our website you are accepting our use of cookies as described in our Privacy Policy. Find Out MoreContinue
Remember Associations only: Forgot password

Compliance, regulation & ethics

Advice and resources on healthcare meeting issues, legal barriers (like Visa), business ethics, dodgy vs. quality events and financial models of meetings.
We explore the different perspectives on the current COVID-19 crisis: from an association, a professional congress organiser, a destination and an insurance broker.

Having been introduced to the meetings industry just three years ago, I have come to learn many interesting and exciting things, one of them being questionable conferences, organisers and journals.

A major artificial intelligence (AI) conference will be held in Africa in 2020—because the organizers admit it will be more difficult for African researchers to get foreign visas to attend it elsewhere.

How come medical event organizers do not make the most out of digital technology; and do not follow the ever changing needs of patients and doctors? Read on to learn the 4 key ways to catapult any medical event into the 21st century.

Predatory conferences, endemic to the nation's peer review system, prey on the need for academics and students to present and publish their work, while reaping huge profits for the organizers.

It doesn’t take Einstein to conclude that motivation and empowerment are the key to retaining your human capital, yet it appears that some organisations – large and small alike, are still failing to recognize this key facet as something not to be tak

How much (electronic) ink have I spilled holding forth about savings and compliance being the rationales for the establishment of a meetings management program?

Pharmaceutical companies that belong to the European Federation of Pharmaceutical Industries and Associations (EFPIA),

Industry associations have joined forces to create a set of guidelines to help members understand the new Construction, Design & Management (CDM) 2015 regulations.

Each year, tens of thousands of healthcare professionals from around the world attend medical conventions in the United States.

The term Strategic Meetings Management (SMM) has been kicking around for the best part of 20 years, having originated in the North American meetings and events industry.

It’s safe to say that human trafficking is the hot topic in the travel and tourism industry.

Those of us who have the great fortune of working in the travel industry know the value of face-to-face meetings:

Pharma giant GlaxoSmithKline (GSK) has been fined almost £300 million after a Chinese court found it guilty of bribery.

Inaugural Healthcare Meetings Forum discusses implications of regulation. Medical meetings in Asia were given a thorough examination at a special Forum held recently.

This question is asked during every training, conference session, and webinar I present, without fail.

The Centers for Medicare and Medicaid Services gave continuing medical education providers both a trick and a treat on Halloween when it issued its final rules relating to Open Payments (formerly known as the Sunshine Act).

Compliance is set to be the issue most likely to keep planners awake at night in 2015, according to CWT Meetings & Events' 2015 Meetings & Events Forecast

Nestlé has said it was 'very disappointed' a health conference was cancelled after senior NHS figures urged a boycott over its sponsorship.

I frequently write about the limited adoption of strategic meetings management programs by organizations that are leaving themselves highly exposed from regulatory, duty-of-care, and fiduciary perspectives.

Almost three quarters of earnings in association sector come from medical meetings.

I recently had the pleasure of speaking with a group of hoteliers and buyers in the life sciences sector about the challenges they face in meeting each other’s needs.

This was the fifth IPCAA (International Pharmaceutical Congress Advisory) Association compliance seminar and there was, more than ever, the need for the medical societie